日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

KPT-9274(一种首创的PAK4和NAMPT双重抑制剂)在晚期实体恶性肿瘤患者中的首次人体I期研究

Razak, Albiruni; Mahipal, Amit; Diamond, Jennifer R; Ribas, Antoni; Berlin, Jordan David; Azmi, Asfar S; Mark, Tomer; Walker, Christopher J; Chai, Yi; Kashyap, Trinayan; Gudi, Girish; Naing, Aung

Evaluating the quality of online patient education materials for gastric adenocarcinoma

评估胃腺癌在线患者教育材料的质量

Ray, Trisha; Barrow, Taylor; Hamel, Lauren; Al Hallak, Najeeb; Azmi, Asfar S; Shields, Anthony; Kim, Steve; Tobon, Miguel; Beal, Eliza W

Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways

MEN1野生型低级别转移性胰腺NET的基因组和转录组图谱揭示了关键的致癌驱动因素和可靶向通路

Uddin, Md Hafiz; Mahdi, Zaid; Muqbil, Irfana; Herring, Brendon R; Rose, Bart; Khan, Husain Y; Li, Yiwei; Aboukameel, Amro; Bannoura, Sahar F; Jimenez, Hugo; Johansen, Allan; Al-Hallak, Mohammad Najeeb; Azar, Ibrahim; Mohamed, Amr; Hadid, Tarik; Vaishampayan, Nitin; Shi, Yang; Wan, Yin; Ong, Vy; Dyson, Gregory; Beydoun, Rafic; Tobon, Miguel; Beal, Eliza W; Chen, Herbert; Shields, Anthony F; Philip, Philip A; Beebe-Dimmer, Jennifer; Mohammad, Ramzi M; Pasche, Boris C; El-Rayes, Bassel F; Azmi, Asfar S

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2Ar and NPM1-m AML

Menin 和 XPO1 联合抑制可协同增强 KMT2Ar 和 NPM1-m AML 的抗白血病活性。

Uddin, Md Hafiz; Dhiman, Sandhya; Han, Yufen; Aboukameel, Amro; Dhillon, Vikram; Aguillar, Jeff; Buck, Steven; Deol, Abhinav; Boerner, Julie L; Polin, Lisa; Kessler, Linda; Burrows, Francis; Yang, Jay; Azmi, Asfar S; Maciejewski, Jaroslaw P; Cutler, Jevon; Du, Yang; Balasubramanian, Suresh Kumar

ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma

ADT-030 是一种新型 PDE10 抑制剂,在胰腺导管腺癌中表现出强大的抗肿瘤活性。

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji Purnachandra; Sarvesh, Sujith; Foote, Jeremy B; Keeton, Adam B; Chen, Xi; Ramirez-Alcantara, Veronica; Holmes, Thomas; Akce, Mehmet; Singh, Anju; Powell, Craig M; Behera, Santosh; Azmi, Asfar S; Nurmemmedov, Elmar; Babic, Ivan; Gorman, Gregory S; Coward, Lori; Buchsbaum, Donald J; Maxuitenko, Yulia Y; Piazza, Gary A; El-Rayes, Bassel F

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges

靶向KRAS突变:调控癌症演变和治疗挑战

Choucair, Khalil; Imtiaz, Hafsa; Uddin, Md Hafiz; Nagasaka, Misako; Al-Hallak, Mohammad Najeeb; Philip, Philip A; El-Rayes, Bassel; Pasche, Boris C; Azmi, Asfar S

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

ADT-1004:一种首创的口服泛RAS抑制剂,在胰腺导管腺癌的临床前模型中具有强大的抗肿瘤活性

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji Purnachandra; Sarvesh, Sujith; Carstens, Julienne L; Foote, Jeremy B; Graff, Emily C; Fang, Yu-Hua D; Keeton, Adam B; Chen, Xi; Valiyaveettil, Jacob; Berry, Kristy L; Bae, Sejong; Akce, Mehmet; Gorman, Greg; Yoon, Karina J; Manne, Upender; Boyd, Michael R; Buchsbaum, Donald J; Azmi, Asfar S; Maxuitenko, Yulia Y; Piazza, Gary A; El-Rayes, Bassel F

XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

KRAS突变型癌症中的XPO1抑制:是时候进行临床试验了,但该如何进行?

Nagasaka, Misako; Khan, Husain Y; Luo, Faustine; Al-Hallak, Mohammed Najeeb; Saif, Muhammad Wasif; Mohammad, Ramzi M; Azmi, Asfar S

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer

PCNA抑制增强KRAS靶向疗法在胰腺癌中的抗肿瘤活性

Bannoura, Sahar F; Khan, Husain Yar; Aboukameel, Amro; Wan, Yin; Bao, Bin; Uddin, Md Hafiz; Jimenez, Hugo; Aboukameel, Adeeb; Siddiqui, Rayyan; Khan, Filza; Haratipour, Pouya; Gu, Long; Beydoun, Rafic; Saif, Muhammad Wasif; Tobon, Miguel; Philip, Philip A; El-Rayes, Bassel; Chen, Herbert; Hickey, Robert J; Malkas, Linda; Shi, Yang; Al Hallak, Mohammed Najeeb; Mohammad, Ramzi M; Pasche, Boris C; Azmi, Asfar S

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

联合靶向KRAS和Exportin1是治疗KRASG12D突变型胰腺导管腺癌的有效策略

Khan, Husain Yar; Al Hallak, Mohammed Najeeb; Aboukameel, Amro; Bannoura, Sahar F; Uddin, Md Hafiz; Aboukameel, Adeeb A; Alkan, Fulya Koksalar; Caglayan, Ahmet B; Alkan, Hilmi K; Bao, Bin; Jimenez, Hugo; Johansen, Allan M; McGrath, Callum; Barker, Grayson; Choucair, Khalil; Tubon, Miguel; Beal, Eliza; Kim, Steve; Beydoun, Rafic; Dyson, Gregory; Shi, Yang; Nagasaka, Misako; Atfi, Azeddine; Korkaya, Hasan; Saif, Muhammad Wasif; Philip, Philip A; El-Rayes, Bassel; Chen, Herbert; Shields, Anthony F; Mohammad, Ramzi M; Pasche, Boris C; Azmi, Asfar S